First Narrow-Spectrum Antibiotic Successfully Eliminates Fusobacterium Nucleatum in Breakthrough Study at the ADA Forsyth Institute
September 05, 2024
September 05, 2024
CAMBRIDGE, Massachusetts, Sept. 5 (TNSres) -- The ADA Forsyth Institute issued the following news:
* * *
F. nucleatum triggers the onset of gum disease, and is associated with colon cancer, pancreatic cancer, and Alzheimer's disease
* * *
The ADA Forsyth Institute, a leading oral health research organization, and Flightpath Biosciences Inc are excited to announce a groundbreaking discovery in the fight against severe gum disease and related sys . . .
* * *
F. nucleatum triggers the onset of gum disease, and is associated with colon cancer, pancreatic cancer, and Alzheimer's disease
* * *
The ADA Forsyth Institute, a leading oral health research organization, and Flightpath Biosciences Inc are excited to announce a groundbreaking discovery in the fight against severe gum disease and related sys . . .